T oward the end of 2004, having completed the input sought of me toward an application for The International Journal of Lower Extremity Wounds (IJLEW) to be indexed in MEDLINE, I pondered over and decided to have a thematic issue in 2005. And after considering the wound-healing scene from various angles, I decided to focus this issue of IJLEW on "Ischemia and the Diabetic Foot." In arriving at this decision, I was influenced by unanswered questions such as the following: "This diabetic patient's foot was bleeding well . . . why did it not heal as expected? And does ischemia influence the development of the Charcot foot?" There have been a number of clinical reports of the increasing prevalence of peripheral arterial disease in the diabetic population, and it seemed that an issue that focused on blood flow and the diabetic foot would be revealing.
This issue has a number of exciting pieces. A guest editorial from the master himself (TKH) tells us that it is possible to monitor and fine-tune principle physiological components to optimize blood flow available for healing. For him, ischemia is a relative concept. John Church, whose knowledge of the role of maggot debridement therapy is second to none, elegantly informs us about the efficacy of maggot debridement in the second guest editorial. We need to take note of these comments-they could save a lot of angst and amputation (possibly).
There are articles on the pathogenesis of the diabetic foot, the development of the Charcot foot, and some aspects of the biomechanics of the diabetic foot, all by leading workers from United States and Europe. Com-plications of managing the diabetic foot and, of course, infections in the diabetic foot are also addressed in this issue. The concept of apoptosis as a likely cause of impaired healing of diabetic foot wounds is presented in an article by Shukla and colleagues. This collection of articles is authored by key opinion leaders; interestingly, there is little to confirm or refute my prejudice that ischemia in the diabetic foot is a growing problem. Is this because I am prejudiced or because the evidence has not emerged for us all to be convinced? This is an angle I would like the reader to ponder while considering the next research step or when wondering about the outcome of the clinical audit.
Returning to ischemia momentarily, it would appear that it is not so much a matter of having enough perfusion pressure alone to secure healing. Rather, the availability of adequate oxygen may be more important to guarantee healing. If that is the case, ischemia may have an unrecognized role in the development of the Charcot foot, as argued by William Jeffcoate in this issue.
The International Diabetic Foundation has declared 2005 to be the Year of the Diabetic Foot; I am well pleased that IJLEW is devoting an entire issue to this very worthy program. It has been a fun issue to bring together, made more so by Aristides Veves. Working with Aris (in Boston) has been easy despite the distance (as the crow flies). That is another lesson learnt.
